Management of adrenal incidentaloma

References

• Grumbach MM, Biller BM, Braunstein GD et al. Management of the clinically inapparent adrenal mass (“incidentaloma“). Ann. Intern. Med.138, 424–429 (2003).
   PubMed Web of Science ®Google Scholar
• Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B. Incidentally discovered adrenal masses. Endocr. Rev.16, 460–484 (1995).
   PubMed Web of Science ®Google Scholar
• Young WF. Management approaches to adrenal incidentalomas: a view from Rochester, Minnesota. Endocrinol. Metab. Clin. North. Am.29, 159–185 (2000).
   PubMed Web of Science ®Google Scholar
• Young WF. The incidentally discovered adrenal mass. N. Engl. J. Med.356, 601–610 (2007).
   PubMed Web of Science ®Google Scholar
• Kastelan D, Grubelic Ravic K, Cacic M et al. Severe postoperative hypoglycaemia in a patient with pheochromocytoma and preclinical Cushing’s syndrome. Med. Sci. Mon.13, 34–37 (2007).
   Google Scholar
• Bülow B, Ahrén B; Swedish Research Council Study Group of Endocrine Abdominal Tumours. Adrenal incidentaloma experience of a standardized diagnostic programme in the Swedish prospective study. J. Intern. Med.252, 239–246 (2002).
   PubMed Web of Science ®Google Scholar
• Bülow B, Jansson S, Juhlin C et al. Adrenal incidentaloma – follow-up results from a Swedish prospective study. Eur. J. Endocrinol.154, 419–423 (2006).
   PubMed Web of Science ®Google Scholar
• Mantero F, Terzolo M, Arnaldi G et al. A survey of adrenal incidentaloma in Italy. J. Clin. Endocrinol. Metab.85, 637–644 (2000).
   PubMed Web of Science ®Google Scholar
• Comlekci A, Yener S, Ertilav S et al. Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience. Endocrine37, 40–46 (2010).
   PubMed Web of Science ®Google Scholar
• Terzolo M, Stigliano A, Chiodini I et al. Italian Association of Clinical Endocrinologists. AME position statement on adrenal incidentaloma. Eur. J. Endocrinol.164, 851–870 (2011).
   PubMed Web of Science ®Google Scholar
• Vassiliadi DA, Ntali G, Vicha E, Tsagarakis S. High prevalence of subclinical hypercortisolism in patients with bilateral adrenal incidentalomas: a challenge to management. Clin. Endocrinol.74, 438–444 (2011).
   PubMed Web of Science ®Google Scholar
• Kasperlik-Zaluska AA, Roslonowska E, Slowinska-Srzednicka J et al. 1,111 patients with adrenal incidentalomas observed at a single endocrinological center: incidence of chromaffin tumors. Ann. NY Acad. Sci.1073, 38–46 (2006).
   PubMed Web of Science ®Google Scholar
• Motta-Ramirez GA, Remer EM, Herts BR, Gill IS, Hamrahian AH. Comparison of CT findings in symptomatic and incidentally discovered pheochromocytomas. Am. J. Roentgenol.185, 684–688 (2005).
   PubMed Web of Science ®Google Scholar
• Quint LE, Glazer GM, Francis IR, Shapiro B, Chenevert TL. Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy. Radiology165, 89–93 (1987).
   PubMed Web of Science ®Google Scholar
• Ilias I, Pacak K. Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma. J. Clin. Endocrinol. Metab.89, 479–491 (2004).
   PubMed Web of Science ®Google Scholar
• Terzolo M, Bovio S, Pia A, Reimondo G, Angeli A. Management of adrenal incidentaloma. Best Pract. Res. Clin. Endocrinol. Metab.23, 233–243 (2009).
   PubMed Web of Science ®Google Scholar
• Sawka AM, Jaeschke R, Singh RJ, Young WF Jr. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J. Clin. Endocrinol. Metab.88, 553–558 (2003).
   PubMed Web of Science ®Google Scholar
• Lenders JW, Pacak K, Walther MM et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA287, 1427–1434 (2002).
   PubMed Web of Science ®Google Scholar
• Terzolo M, Bovio S, Pia A et al. Subclinical Cushing’s syndrome. Arq. Bras. Endocrinol. Metabol.51, 1272–1279 (2007).
   PubMedGoogle Scholar
• Ambrosi B, Peverelli S, Passini E et al. Abnormalities of endocrine function in patients with clinically silent adrenal masses. Eur. J. Endocrinol.132, 422–428 (1995).
   PubMed Web of Science ®Google Scholar
• Caplan RH, Strutt PJ, Wickus GG. Subclinical hormone secretion by incidentally discovered adrenal masses. Arch. Surg.129, 291–296 (1994).
   PubMedGoogle Scholar
• Flecchia D, Mazza E, Carlini M et al. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour. Clin. Endocrinol.42, 129–134 (1995).
   PubMed Web of Science ®Google Scholar
• Morelli V, Masserini B, Salcuni AS et al. Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects. Clin. Endocrinol.73, 161–166 (2010).
   PubMed Web of Science ®Google Scholar
• Arnaldi G, Angeli A, Atkinson AB et al. Diagnosis and complications of Cushing’s syndrome: a consensus statement. J. Clin. Endocrinol. Metab.88, 5593–5602 (2003).
   PubMed Web of Science ®Google Scholar
• Terzolo M, Osella G, Alì A et al. Subclinical Cushing’s syndrome in adrenal incidentaloma. Clin. Endocrinol.48, 89–97 (1998).
   PubMed Web of Science ®Google Scholar
• Terzolo M, Pia A, Ali A et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? J. Clin. Endocrinol.Metab.87, 998–1003 (2002).
   PubMed Web of Science ®Google Scholar
• Giordano R, Marinazzo E, Berardelli R et al. Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas. Eur. J. Endocrinol.162, 779–785 (2010).
   PubMed Web of Science ®Google Scholar
• Emral R, Uysal AR, Asik M et al. Prevalence of subclinical Cushing’s syndrome in 70 patients with adrenal incidentaloma: clinical, biochemical and surgical outcomes. Endocr. J.50, 399–408 (2003).
   PubMed Web of Science ®Google Scholar
• Tauchmanovà L, Rossi R, Biondi B et al. Patients with subclinical Cushing’s syndrome due to adrenal adenoma have increased cardiovascular risk. J. Clin. Endocrinol. Metab.87, 4872–4878 (2002).
   PubMed Web of Science ®Google Scholar
• Torlontano M, Chiodini I, Pileri M et al. Altered bone mass and turnover in female patients with adrenal incidentaloma: the effect of subclinical hypercortisolism. J. Clin. Endocrinol. Metab.84, 2381–2385 (1999).
   PubMed Web of Science ®Google Scholar
• Chiodini I, Torlontano M, Carnevale V et al. Bone loss rate in adrenal incidentalomas: a longitudinal study. J. Clin. Endocrinol. Metab.86, 5337–5341 (2001).
   PubMed Web of Science ®Google Scholar
• Bernini GP, Moretti A, Oriandini C, Bardini M, Taurino C, Salvetti A. Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas. Br. J. Cancer92, 1104–1109 (2005).
   PubMed Web of Science ®Google Scholar
• Vassilatou E, Vryonidou A, Michalopoulou S et al. Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study. Clin. Endocrinol.70, 674–679 (2009).
   PubMed Web of Science ®Google Scholar
• Barzon L, Sonino N, Fallo F, Palu G, Boscaro M. Prevalence and natural history of adrenal incidentalomas. Eur. J. Endocrinol.149, 273–285 (2003).
   PubMed Web of Science ®Google Scholar
• Mulatero P, Stowasser M, Loh KC et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J. Clin. Endocrinol. Metab.89, 1045–1050 (2004).
   PubMed Web of Science ®Google Scholar
• Weinberger MH, Fineberg NS. The diagnosis of primary aldosteronism and separation of two major subtypes. Arch. Intern. Med.153, 2125–2129 (1993).
   PubMedGoogle Scholar
• Young WF. Primary aldosteronism: renaissance of a syndrome. Clin. Endocrinol.66, 607–618 (2007).
   PubMed Web of Science ®Google Scholar
• Sturgeon C, Shen WT, Clark OH, Duh QY, Kebebew E. Risk assesment in 457 adrenal cortical carcinomas: how much does tumour size predict the likelihood of malignancy? J. Am. Coll. Surg.202, 423–430 (2006).
   PubMed Web of Science ®Google Scholar
• Pantalone KM, Gopan T, Remer EM et al. Change in adrenal mass size as a predictor of a malignant tumor. Endocr. Pract.16, 577–587 (2010).
   PubMed Web of Science ®Google Scholar
• Szolar DH, Korobkin M, Reittner P et al. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology234, 479–485 (2005).
   PubMed Web of Science ®Google Scholar
• Hamrahian AH, Ioachimescu AG, Remer EM et al. Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: Cleveland Clinic experience. J. Clin. Endocrinol. Metab.90, 871–877 (2005).
   PubMed Web of Science ®Google Scholar
• Szolar DH, Kammerhuber FH. Adrenal adenomas and non adenomas: assesment of washout at delayed contrast-enhanced CT. Radiology207, 369–375 (1998).
   PubMed Web of Science ®Google Scholar
• Lutz A, Stojkovic M, Schmidt M, Arlt W, Allolio B, Reincke M. Adrenocortical function in patients with macrometastases of the adrenal gland. Eur. J. Endocrinol.143, 91–97 (2000).
   PubMed Web of Science ®Google Scholar
• Quayle FJ, Spitler JA, Pierce RA, Lairmore TC, Moley JF, Brunt LM. Needle biopsy of incidentally discovered adrenal masses is rarely informative and potentially hazardous. Surgery142, 497–504 (2007).
   PubMed Web of Science ®Google Scholar
• Yankaskas BC, Staab EV, Craven MB, Blatt PM, Sokhandan M, Carney CN. Delayed complications from fine-needle biopsies of solid masses of the abdomen. Invest. Radiol.21, 325–328 (1986).
   PubMed Web of Science ®Google Scholar
• McCorkell SJ, Niles NL. Fine-needle aspiration of catecholamine-producing adrenal masses: a possibly fatal mistake. Am. J. Roentgenol.145, 113–114 (1985).
   PubMed Web of Science ®Google Scholar
• Habscheid W, Pfeiffer M, Demmrich J, Muller HA. Puncture track metastasis after ultrasound-guided fine-needle puncture biopsy. A rare complication? Dtsch Med. Wochenschr.115, 212–215 (1990).
   PubMed Web of Science ®Google Scholar
• Kastelan D, Dusek T, Aganovic I et al. Management of adrenal incidentaloma: the position statement of the Croatian referral center for adrenal gland disorders. Lijec. Vjesn.132, 71–75 (2010).
   PubMedGoogle Scholar
• Kastelan D, Dzubur F, Dusek T et al. Health-related quality of life and fatigue in patients with adrenal incidentaloma. Endocrine40, 84–89 (2011).
   PubMed Web of Science ®Google Scholar
• Cawood TJ, Hunt PJ, O’Shea D, Cole D, Soule S. Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink? Eur. J. Endocrinol.161, 513–527 (2009).
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Sasagawa, Suzuki H, Izumi T, Kaneko H, Nakada T. The role of ultrasonography in the detection of adrenal masses: comparison with computed tomography and magnetic resonance imaging. Int. Urol. Nephrol.32, 303–306 (2001).
   PubMedGoogle Scholar
• Fontana D, Porpiglia F, Destefanis P et al. What is the role of ultrasonography in the follow-up of adrenal incidentalomas? The Gruppo Piemontese Incidentalomi Surrenalici. Urology54, 612–616 (1999).
   PubMed Web of Science ®Google Scholar
• Alexandraki KI, Grossman AB. Adrenal incidentalomas: ‘the rule of four’. Clin. Med.8, 201–204 (2008).
   PubMed Web of Science ®Google Scholar
• Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr. Rev.25, 309–340 (2004).
   PubMed Web of Science ®Google Scholar
• Bernini G, Moretti A, Iacconi P et al. Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. Eur. J. Endocrinol.148, 213–219 (2003).
   PubMed Web of Science ®Google Scholar
• Toniato A, Merante-Boschin I, Opocher G, Pelizzo MR, Schiavi F, Ballotta E. Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study. Ann. Surg.249, 388–391 (2009).
   PubMed Web of Science ®Google Scholar
• Chiodini I, Morelli V, Salcuni AS et al. Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. J. Clin. Endocrinol. Metab.95, 2736–2745 (2010).
   PubMed Web of Science ®Google Scholar